- Pulmonx press release (NASDAQ:LUNG): Q4 GAAP EPS of -$0.33 beats by $0.11.
- Revenue of $23.8M (+23.5% Y/Y) beats by $1.51M.
- Shares +12.8% AH.
-
The Company expects gross margin for the full year 2025 to be approximately 74%.
Pulmonx expects total operating expenses for the full year 2025 to fall within the range of $133 million to $135 million, inclusive of approximately $22 million of non-cash stock-based compensation.
Pulmonx GAAP EPS of -$0.33 beats by $0.11, revenue of $23.8M beats by $1.51M (NASDAQ:LUNG)
